UK markets open in 6 hours 1 minute
NIKKEI 225
30,762.11 -475.83 (-1.52%) HANG SENG
17,331.22 -478.44 (-2.69%) CRUDE OIL
89.55 +0.32 (+0.36%) GOLD FUTURES
1,840.00 -1.50 (-0.08%) DOW
33,002.38 -430.97 (-1.29%) Bitcoin GBP
22,626.02 -74.35 (-0.33%)
Shield Therapeutics plc (STX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:33PM BST
| Previous close | 7.55 |
| Open | 0.00 |
| Bid | 7.40 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,924,469 |
| Market cap | 72.043M |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Shield Therapeutics First Half 2023 Earnings: US$0.025 loss per share (vs US$0.069 loss in 1H 2022)
Shield Therapeutics ( LON:STX ) First Half 2023 Results Key Financial Results Revenue: US$4.33m (up 69% from 1H 2022...
- Simply Wall St.
Private companies who hold 41% of Shield Therapeutics plc (LON:STX) gained 17%, institutions profited as well
Key Insights Shield Therapeutics' significant private companies ownership suggests that the key decisions are...
- Simply Wall St.
Loss-Making Shield Therapeutics plc (LON:STX) Expected To Breakeven In The Medium-Term
Shield Therapeutics plc ( LON:STX ) is possibly approaching a major achievement in its business, so we would like to...
© 2023 Yahoo. All rights reserved.
